Growth Metrics

BioCorRx (BICX) Asset Writedowns and Impairment (2015 - 2023)

BioCorRx recorded quarterly Asset Writedowns and Impairment of $47980.0 in Q1 2023, up 1311.18% quarter-over-quarter from $3400.0 in Q2 2019.

BioCorRx's Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $47980.0 for Q1 2023.

  • In Q1 2023, Asset Writedowns and Impairment changed N/A year-over-year to $47980.0; the TTM figure through Dec 2023 stood at $47980.0 (changed N/A YoY), while the FY2023 annual figure was $47980.0, changed N/A from the prior year.
  • Asset Writedowns and Impairment came in at $47980.0 for Q1 2023 at BioCorRx, up from $3400.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $47980.0 in Q1 2023 to a low of -$1000.0 in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 BioCorRx - - 189,355.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2023 47,980.00
Mar 31, 2023 47,980.00
Jun 30, 2019 3,400.00
Jun 30, 2019 3,400.00
Mar 31, 2019 -1,000.00
Mar 31, 2019 -1,000.00
Dec 31, 2018 234,250.00
Dec 31, 2018 234,250.00
Sep 30, 2018 3,500.00
Sep 30, 2018 3,500.00
Jun 30, 2018 -3,500.00
Jun 30, 2018 -3,500.00
Mar 31, 2018 15,750.00
Mar 31, 2018 15,750.00
Dec 31, 2017 5,375.00
Dec 31, 2017 5,375.00
Dec 31, 2016 51,000.00
Dec 31, 2016 51,000.00
Jun 30, 2016 6,000.00
Jun 30, 2016 6,000.00
Mar 31, 2016 2,750.00
Mar 31, 2016 2,750.00
Dec 31, 2015 40,400.00
Dec 31, 2015 40,400.00
Sep 30, 2015 47,500.00
Sep 30, 2015 47,500.00